Search Results - Michael Kean

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    <i>In vivo</i> identification of human cortical areas using high-resolution MRI: An approach to cerebral structure–function correlation

    <i>In vivo</i> identification of human cortical areas using high-resolution MRI: An approach to cerebral structure–function correlation by Nathan B. Walters, Gary F. Egan, Jillian J. Kril, Michael Kean, Patricia Waley, Mark Jenkinson, J D Watson

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Language lateralization correlates with verbal memory performance in children with focal epilepsy

    Language lateralization correlates with verbal memory performance in children with focal epilepsy by Regula Everts, A. Simon Harvey, Leasha Lillywhite, Jacquie Wrennall, David F. Abbott, Linda Gonzalez, Michael Kean, Graeme D. Jackson, Vicki Anderson

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Developmental brain trajectories in children with ADHD and controls: a longitudinal neuroimaging study

    Developmental brain trajectories in children with ADHD and controls: a longitudinal neuroimaging study by Timothy J. Silk, Sila Genc, Vicki Anderson, Daryl Efron, Philip Hazell, Jan M. Nicholson, Michael Kean, Charles B. Malpas, Emma Sciberras

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasia

    The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasia by A. Simon Harvey, Simone Mandelstam, Wirginia Maixner, Richard J. Leventer, Mira Semmelroch, Duncan MacGregor, Renate M. Kalnins, Yuliya Perchyonok, Gregory J. Fitt, Sarah Barton, Michael Kean, Gavin Fabinyi, Graeme D. Jackson

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice

    A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice by Ian Woodcock, George Tachas, Nuket Desem, Peter J. Houweling, Michael Kean, Jaiman Emmanuel, Rachel A. Kennedy, Kate Carroll, Katy de Valle, Justine Adams, Shireen R. Lamandé, Chantal A. Coles, Chrystal F. Tiong, Matthew J. Burton, Daniella Villano, Peter Button, Jean‐Yves Hogrel, Sarah Catling-Seyffer, Monique M. Ryan, Martin B. Delatycki, Eppie M. Yiu

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: